CD19 CAR mRNA (Human)
Product Sizes
1 mg (1 mg/mL * 1 mL in Water)
£ POA
HY-153084A-1MG
100 μg (1 mg/mL * 100 μL in Water)
£ POA
HY-153084A-100UG
500 μg (1 mg/mL * 500 μL in Water)
£ POA
HY-153084A-500UG
About this Product
- SKU:
- HY-153084A
- Application:
- Antibody Microarray
- Extra Details:
- CD19 CAR mRNA (Human) expresses CAR protein that specifically targets human CD19. CD19 CAR mRNA can trigger transitory expression of CAR; allowing T cells to be targeted without permanent genetic modification. CD19 CAR mRNA targets CD19 which is a transmembrane glycoprotein primarily expressed on B lymphocytes and is important in B cell activation. CD19 CAR mRNA can be studied in cancer research such as lymphoma and leukemia[1][2][3].
- Molecular Weight:
- N/A
- Purity:
- 97.10
- References:
- [1]K. Xiao, et al., mRNA-based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions Interdiscip. Med. 2024, 2, e20230036. |[2]Wang, K., et al., (2012). CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Experimental hematology & oncology, 1(1), 36.|[3]Wu, J., et al., (2024). Chimeric antigen receptor therapy meets mRNA technology. Trends in biotechnology, 42(2), 228–240.
- Research Area:
- Cancer
- Shipping Conditions:
- Dry Ice
- Storage Conditions:
- -80[o]C
- Type:
- Molecular Biology Reagents: Nucleic Acids
- Pathway:
- Immunology/Inflammation
